If you are:
FDB Contraindicated or Not Recommended: FDA CATEGORY C;SALICYLATES NOT RECOMMENDED ESPECIALLY IN 3RD TRIMESTER/NEAR TERM
Absolute Contraindication: MANUFACTURER DOES NOT RECOMMEND. LIMITED HUMAN DATA.
An adult over 60:
management or monitoring precaution: Gastrointestinal-Increased risk for ulceration or serious to fatal GI bleed. The risk is highest with history of PUD or GI bleed. Renal-Increased risk for exacerbation of chronic renal failure. Cardiovascular-May exacerbate pre-existing hypertension or chronic heart failure. Risk for reinfarction is elevated with even minimal NSAID use post-MI. Hepatic-Elevated hepatic transaminases may occur with chronic use.
Giving Dolobid tablet to a child under 12:
Contraindication: Safety and efficacy not established. Not recommended age < 12 years.